Wang Zhiwen, Jiang Weimin, Zhang Zongyu, Wang Heng, Li Xuefeng, Shi Jinhui, Chen Jie, Yang Huilin
Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215006, China. Email:
Zhonghua Wai Ke Za Zhi. 2014 Jun;52(6):425-30.
To study clinical outcomes following anterior cervical discectomy and fusion (ACDF) using ROI-C compared to traditional cage with anterior plating in treating the cervical spondylotic myelopathy.
A total of 66 patients with the cervical spondylotic myelopathy were treated with ACDF between April 2011 and October 2012. Twenty-three patients underwent ACDF using the ROI-C device were classified as the ROI-C group and 43 patients received traditional cage with anterior plating served as the titanium plate group. Related indicators, such as operation time, intraoperative blood loss, intraoperative fluoroscopy times, incidence of postoperative dysphagia and ratio of bone graft fusion were recorded and compared between two groups. The clinical outcomes were evaluated by Japanese Orthopaedic Association (JOA) scores and visual analog scale (VAS) scores. The pre- and postoperative results were compared with a paired sample t-test. The results between groups were compared utilizing the grouped t-test or χ² test.
All cases were followed up. The follow-up period was 12 to 38 months and 14 to 39 months in ROI-C group and titanium plate group respectively. For the age, gender, the JOA scores, VAS scores of neck pain and arm pain during preoperative, the surgical level constituent ratio and the follow-up time, there were no significant differences between two groups. In ROI-C group, the operation time was (123 ± 38) minutes, intraoperative blood loss was (84 ± 37)ml, exposure times to the X-ray C-arm machine was (3.5 ± 0.7) times, which were all significantly lower than titanium plate group ((165 ± 60) minutes, (128 ± 66) ml, (5.9 ± 1.2) times respectively, t = -3.27, -3.25, - 9.45, P = 0.02, 0.02, 0.00). The mean JOA scores increased significantly from pre-surgery to 1 month postoperatively, 3 months postoperatively, and last follow-up in ROI-C group (t = 11.94, 11.32, 10.60, all P = 0.00) and titanium plate group(t = 15.07, 19.51, 17.55, all P = 0.00). The mean VAS scores of neck pain and arm pain decreased significantly from pre-surgery to 1 month postoperatively, 3 months postoperatively, and last follow-up in ROI-C group (t = -16.64-- 9.68, all P = 0.00) and titanium group(t = -16.56--12.38, all P = 0.00). There was no significant difference on JOA scores and VAS scores of neck pain and arm pain between the two groups at the same time (P > 0.05). However, significant difference was observed in incidence of postoperative dysphagia (χ² = 6.79, P = 0.01). In addition, bony fusion was obtained in all cases at the last follow-up postoperatively. There was no significant difference on ratio of bone graft fusion between two groups.
The ROI-C leads to similar clinical outcomes compared to traditional cage combined with anterior plating for the treatment of the cervical spondylotic myelopathy, while the ROI-C carries a simpler operation, shorter operation time, less intraoperative blood loss, less exposure times to the X-ray and a lower risk of postoperative dysphagia.
研究采用ROI-C进行颈椎前路椎间盘切除融合术(ACDF)与传统椎间融合器联合前路钢板治疗脊髓型颈椎病的临床疗效。
2011年4月至2012年10月期间,共有66例脊髓型颈椎病患者接受了ACDF治疗。23例行ROI-C器械ACDF的患者被归为ROI-C组,43例接受传统椎间融合器联合前路钢板治疗的患者作为钛板组。记录并比较两组的相关指标,如手术时间、术中出血量、术中透视次数、术后吞咽困难发生率及植骨融合率。采用日本骨科学会(JOA)评分和视觉模拟量表(VAS)评分评估临床疗效。术前和术后结果采用配对样本t检验进行比较。组间结果采用成组t检验或χ²检验进行比较。
所有病例均获随访。ROI-C组和钛板组的随访时间分别为12至38个月和14至39个月。在年龄、性别、术前JOA评分、颈部疼痛和手臂疼痛的VAS评分、手术节段构成比及随访时间方面,两组间无显著差异。ROI-C组的手术时间为(123±38)分钟,术中出血量为(84±37)ml,X线C形臂机暴露次数为(3.5±0.7)次,均显著低于钛板组(分别为(165±60)分钟、(128±66)ml、(5.9±1.2)次,t=-3.27、-3.25、-9.45,P=0.02、0.02、0.00)。ROI-C组和钛板组从术前到术后1个月、术后3个月及末次随访时JOA平均评分均显著增加(ROI-C组:t=11.94、11.32、10.60,P均=0.00;钛板组:t=15.07、19.51、17.55,P均=0.00)。ROI-C组和钛板组从术前到术后1个月、术后3个月及末次随访时颈部疼痛和手臂疼痛的VAS平均评分均显著降低(ROI-C组:t=-16.64至-9.68,P均=0.00;钛板组:t=-16.56至-12.38,P均=0.00)。两组在同一时间的JOA评分及颈部疼痛和手臂疼痛的VAS评分无显著差异(P>0.05)。然而,术后吞咽困难发生率存在显著差异(χ²=6.79,P=0.01)。此外,所有病例术后末次随访时均获得了骨性融合。两组间植骨融合率无显著差异。
与传统椎间融合器联合前路钢板治疗脊髓型颈椎病相比,ROI-C具有相似的临床疗效,同时手术操作更简单,手术时间更短,术中出血量更少,X线暴露次数更少,术后吞咽困难风险更低。